Announcement of the Resolutions of the Fifteenth Meeting of the Eighth Supervisory Board of Shanghai Pharmaceuticals Group Co., Ltd.
Securities code: 601607 Securities abbreviation: Shanghai Pharmaceuticals No.: Lin 2025-101
Shanghai Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the Fifteenth Meeting of the Eighth Supervisory Board
The Company's Supervisory Committee and all supervisors guarantee that there are no false records, misleading statements or major omissions in this announcement, and bear individual and joint liability for the authenticity, accuracy and completeness of its contents.
The 15th meeting of the 8th Supervisory Board of Shanghai Pharmaceuticals Group Co., Ltd. (hereinafter referred to as the "Company" or "Shanghai Pharmaceuticals") (hereinafter referred to as the "meeting") was held on November 6, 2025 via communication. Three supervisors should be present at this meeting, and actually three supervisors were present, which complied with the provisions of the Company Law of the People's Republic of China and the Company's Articles of Association regarding the quorum for convening a board of supervisors meeting. The following proposals were considered and approved at this meeting:
1. "Proposal on Abolition of the Board of Supervisors and Amendment to the Articles of Association and its Annexes"
In order to fully implement laws, regulations and regulatory requirements and further improve the level of corporate governance, in accordance with the "Company Law of the People's Republic of China", "Securities Law of the People's Republic of China", "Guidelines on the Articles of Association of Listed Companies", "Rules of Shareholders' Meetings of Listed Companies", "Stock Listing Rules of the Shanghai Stock Exchange" and other relevant laws, regulations and norms According to the provisions of the statutory documents and combined with the actual situation of corporate governance reform, the company plans to cancel the board of supervisors and let the audit committee of the board of directors exercise the powers of the board of supervisors stipulated in the "Company Law"; revise the "Articles of Association" and the attachments "Rules of Procedure for the Shareholders' Meeting" and "Rules of Procedure for the Board of Directors", and abolish the "Rules of Procedure for the Board of Supervisors".
Voting results: 3 votes in favor, 0 votes against, 0 abstentions
This proposal still needs to be submitted to the company's shareholders' meeting for review.
Announcement is hereby made.
Board of Supervisors of Shanghai Pharmaceutical Group Co., Ltd.
November 7, 2025